Long-Term Biologic Use May Not Raise Melanoma Risk

NEW YORK (Reuters Health)—Patients treated with biologic therapy for rheumatoid arthritis, inflammatory bowel disease and psoriasis don’t appear to be at increased risk of melanoma, according to the results of a systematic review and meta-analysis. However, because the study found trends toward increased melanoma rates with long-term therapy, “a clinically meaningful increase in risk cannot... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Drug Updates Biologics melanoma skin skin cancer Source Type: research